Gabelli Funds’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.86M Sell
44,500
-12,100
-21% -$1.16M 0.03% 568
2025
Q4
$5.44M Sell
56,600
-21,400
-27% -$2.08M 0.04% 471
2025
Q3
$7.43M Sell
78,000
-1,290
-2% -$119K 0.05% 398
2025
Q2
$6.91M Sell
79,290
-2,000
-2% -$170K 0.05% 403
2025
Q1
$7.3M Hold
81,290
0.06% 361
2024
Q4
$6.49M Hold
81,290
0.05% 384
2024
Q3
$7.32M Hold
81,290
0.05% 371
2024
Q2
$6.4M Sell
81,290
-1,700
-2% -$139K 0.05% 392
2024
Q1
$7.23M Sell
82,990
-300
-0.4% -$25.6K 0.05% 369
2023
Q4
$6.86M Sell
83,290
-6,300
-7% -$480K 0.05% 368
2023
Q3
$7.02M Sell
89,590
-3,950
-4% -$331K 0.06% 365
2023
Q2
$8.24M Sell
93,540
-2,500
-3% -$215K 0.06% 342
2023
Q1
$7.74M Sell
96,040
-800
-0.8% -$65.2K 0.06% 365
2022
Q4
$7.53M Buy
96,840
+90
+0.1% +$7.29K 0.06% 366
2022
Q3
$7.81M Sell
96,750
-65,250
-40% -$5.86M 0.06% 352
2022
Q2
$14.5M Sell
162,000
-68,900
-30% -$6.98M 0.11% 256
2022
Q1
$25.6M Buy
230,900
+85,160
+58% +$9M 0.17% 162
2021
Q4
$15.1M Sell
145,740
-132,075
-48% -$15.3M 0.1% 267
2021
Q3
$34.8M Buy
277,815
+34,400
+14% +$4.45M 0.23% 122
2021
Q2
$30.2M Buy
243,415
+25,268
+12% +$3.17M 0.19% 138
2021
Q1
$25.8M Buy
218,147
+26,347
+14% +$3.09M 0.17% 154
2020
Q4
$22.5M Buy
191,800
+30,100
+19% +$3.31M 0.16% 166
2020
Q3
$16.8M Sell
161,700
-20,600
-11% -$2.07M 0.13% 200
2020
Q2
$16.7M Sell
182,300
-22,400
-11% -$2.15M 0.14% 194
2020
Q1
$18.5M Buy
204,700
+91,600
+81% +$9.75M 0.16% 161
2019
Q4
$12.8M Hold
113,100
0.08% 293
2019
Q3
$12.3M Hold
113,100
0.08% 299
2019
Q2
$11M Sell
113,100
-4,800
-4% -$438K 0.07% 329
2019
Q1
$10.7M Buy
117,900
+5,200
+5% +$465K 0.07% 351
2018
Q4
$10.3M Hold
112,700
0.07% 344
2018
Q3
$11.1M Hold
112,700
0.06% 369
2018
Q2
$9.65M Buy
112,700
+200
+0.2% +$16.7K 0.06% 392
2018
Q1
$9.03M Hold
112,500
0.05% 400
2017
Q4
$9.08M Buy
112,500
+36,500
+48% +$2.92M 0.05% 412
2017
Q3
$5.91M Buy
76,000
+11,000
+17% +$913K 0.03% 539
2017
Q2
$5.77M Hold
65,000
0.03% 527
2017
Q1
$5.24M Hold
65,000
0.03% 552
2016
Q4
$4.63M Sell
65,000
-90,422
-58% -$7.1M 0.03% 566
2016
Q3
$13.4M Sell
155,422
-20,000
-11% -$1.74M 0.08% 322
2016
Q2
$15.2M Sell
175,422
-129,420
-42% -$10.5M 0.09% 302
2016
Q1
$22.9M Sell
304,842
-17,340
-5% -$1.31M 0.14% 209
2015
Q4
$24.8M Sell
322,182
-5,200
-2% -$391K 0.15% 191
2015
Q3
$21.9M Sell
327,382
-21,000
-6% -$1.55M 0.13% 216
2015
Q2
$25.8M Sell
348,382
-98,120
-22% -$7.5M 0.14% 216
2015
Q1
$34.8M Buy
446,502
+381,502
+587% +$28.9M 0.18% 181
2014
Q4
$4.69M Sell
65,000
-35,000
-35% -$2.43M 0.02% 603
2014
Q3
$6.2M Hold
100,000
0.03% 539
2014
Q2
$6.38M Hold
100,000
0.03% 550
2014
Q1
$6.15M Buy
100,000
+35,000
+54% +$2.04M 0.03% 535
2013
Q4
$3.73M Sell
65,000
-120,000
-65% -$6.8M 0.02% 634
2013
Q3
$9.85M Buy
185,000
+125,000
+208% +$6.73M 0.06% 406
2013
Q2
$3.09M Buy
+60,000
New +$2.97M 0.02% 631

Other funds holding MDT

Gabelli Funds's MDT Position: Q1 2026 in Review

Gabelli Funds reduced its Medtronic (MDT) stake by 21% in Q1 2026, selling an estimated $1.16M and leaving 44,500 shares worth $3.86M. The position accounts for 0.03% of the portfolio, ranked #568.

Gabelli Funds first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $34.8M in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Gabelli Funds held 44,500 shares of Medtronic worth $3.86M as of Q1 2026.
  • Gabelli Funds sold 12,100 Medtronic shares in Q1 2026, an estimated $1.16M.
  • Medtronic made up 0.03% of Gabelli Funds's portfolio in Q1 2026, its #568 holding.
  • Gabelli Funds first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Gabelli Funds's Medtronic position peaked at $34.8M in Q3 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Gabelli Funds's 13F filing for Q1 2026, filed 14 May 2026.